Delivery Order SPE2DB22D3016-SPE2DB24FBAZ4

Award Date 7/15/24
Potential Completion Date 8/5/24
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,880.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Venclexta 100 mg tablets. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 2, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,880.15 firm fixed-price delivery order is for the supply of Venclexta 100 mg tablets. The contract has an ultimate completion date of April 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug Venclexta 100 mg tablets. The contract is a delivery order with a firm fixed price of $8,880.15 and a completion date of May 16, 2024. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Venclexta 100 mg tablets, a prescription medication, to the government. The contract has a ceiling value of $26,640.45 and a completion date of July 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $29,184.51, is for the delivery of Venclexta 100 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Venclexta 100 mg tablets, a prescription medication. The contract has a ceiling value of $9,728.17 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,092.52, is for the delivery of Venclexta 50 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 22, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $8,880.15 firm fixed price delivery order is for the supply of the prescription drug Venclexta 100 mg tablets. The contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is the primary supplier of pharmaceutical products and medical supplies to DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $88,801.50 firm-fixed-price delivery order is for the supply of Venclexta 100 mg tablets. The contract has an ultimate completion date of August 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,880.15 contract is for the delivery of 4,564,618,747 units of the prescription medication Venclexta 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of June 6, 2024. This contract award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBAZ4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Venclexta 100 mg tablets. The contract is a Delivery Order valued at $8,880.15 with a firm fixed price, and has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific contract award does not have a set-aside designation.

Generated 10/14/24, 10:13 AM